Personal information

Emails & domains

Verified email addresses

Verified email domains

Keywords

Human Immunology, T cells, NK cells, Malaria, EBV, CMV, Cancer

Activities

Collapse all

Employment (3)

University of Massachusetts Medical School: Worcester, MA, US

2019-02-25 to 2021-03-15 | Research Specialist (Division of Infectious Disease, Department of Medicine)
Employment
Source: Self-asserted source
Catherine Forconi

University of Massachusetts Medical School: Worcester, MA, US

2015-01-20 to 2019-02-24 | Post-Doc Associate (Division of Infectious Disease, Department of Medicine)
Employment
Source: Self-asserted source
Catherine Forconi

Centre Hospitalier et de Recherche Universitaire de Tours: Tours, FR

2014-01-01 to 2014-10-01 | Post-Doctoral (Nephrology, Laboratoire Cellules Dendritiques et Greffes)
Employment
Source: Self-asserted source
Catherine Forconi

Education and qualifications (5)

Université de Tours: Tours, Centre, FR

2009-10-01 to 2013-12-17 | DSC/PhD (Immunology, Infectiology, Vaccinology)
Education
Source: Self-asserted source
Catherine Forconi

Université de Tours: Tours, Centre, FR

2007-09-01 to 2009-07-01 | MS (Immunology, Infectiology and Vaccinology)
Education
Source: Self-asserted source
Catherine Forconi

Université de Nantes: Nantes, Pays de la Loire, FR

2004-09-01 to 2007-06-01 | BS (Molecular Biology, Biochemistry, Immunology)
Education
Source: Self-asserted source
Catherine Forconi

Université de Nantes: Nantes, Pays de la Loire, FR

2002-09-01 to 2004-06-01 | N/A (Medicine)
Education
Source: Self-asserted source
Catherine Forconi

Lycée La Colinière: Nantes, FR

1999-09-01 to 2002-07-01 | Scientific High School diploma degree (Loire Atlantique)
Education
Source: Self-asserted source
Catherine Forconi

Professional activities (1)

Alex's Lemonade Stand Foundation: Philadelphia, Pennsylvania, US

2019-07-01 | Young Investigator Grant (Childhood Cancer)
Distinction
Source: Self-asserted source
Catherine Forconi

Funding (5)

The impact of CD56neg NK cells in the pathogenesis of endemic Burkitt lymphoma

2019-07 to 2022-07 | Grant
Alex's Lemonade Stand Foundation for Childhood Cancer (PA, PA, US)
GRANT_NUMBER: ALSF-YIG2019-Forconi
Source: Self-asserted source
Catherine Forconi

Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria

2017-08-11 to 2022-07-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://grants.uberresearch.com/100000060/R01AI127699/Tfh-responses-to-novel-vaccine-candidates-and-protection-from-pediatric-falciparum-malaria
Part of GRANT_NUMBER: R01AI127699
Source: Self-asserted source
Catherine Forconi

Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria

2017-08-11 to 2022-07-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://grants.uberresearch.com/100000060/R01AI127699/Tfh-responses-to-novel-vaccine-candidates-and-protection-from-pediatric-falciparum-malaria
GRANT_NUMBER: R01AI127699
Source: Self-asserted source
Catherine Forconi via DimensionsWizard

Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma

2014-07-10 to 2019-05-31 | Grant
National Cancer Institute (Rockville, US)
URL: https://grants.uberresearch.com/100000054/R01CA189806/Impact-of-malaria-on-shaping-immunity-to-EBV-in-the-etiology-of-Burkitt-lymphoma
Part of GRANT_NUMBER: R01CA189806
Source: Self-asserted source
Catherine Forconi

Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma

Source: Self-asserted source
Catherine Forconi via DimensionsWizard

Works (22)

T follicular helper cell profiles differ by malaria antigen and for children compared to adults

2024-04-16 | Preprint
DOI: 10.1101/2024.04.13.589352
Contributors: Catherine S. Forconi; Christina Nixon; Hannah W. Wu; Boaz Odwar; Sunthorn Pond-Tor; John M. Ong’echa; Jonathan Kurtis; Ann M. Moormann
Source: check_circle
Crossref

The intestinal microbiota predicts COVID-19 severity and fatality regardless of hospital feeding method.

mSystems
2023-08-07 | Journal article | Author
DOI: 10.1128/msystems.00310-23
PMID: 37548476
PMC: PMC10469851
Contributors: Vanni Bucci; Ward DV; Bhattarai S; Rojas-Correa M; Purkayastha A; Holler D; Qu MD; Mitchell WG; Jason Yang; Fountain S et al.
Source: Self-asserted source
Catherine Forconi

Distinctive Kaposi Sarcoma-Associated Herpesvirus Serological Profile during Acute <i>Plasmodium falciparum</i> Malaria Episodes

International Journal of Molecular Sciences
2023-04 | Journal article | Author
DOI: 10.3390/ijms24076711
Contributors: Peter Oluoch; Catherine Forconi; Cliff I. Oduor; Dominic A. Ritacco; Hoseah Akala; Jeffrey A. Bailey; Jonathan J. Juliano; John Ong'echa; Christian Münz; Ann Moormann
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies.

Life science alliance
2023-03-06 | Journal article
DOI: 10.26508/lsa.202101355
PMID: 36878637
PMC: PMC9990458
Contributors: Saikumar Lakshmi P; Oduor CI; Forconi CS; M'Bana V; Bly C; Gerstein RM; Otieno JA; John Ong'echa; Münz C; Micah Luftig et al.
Source: Self-asserted source
Catherine Forconi

SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the Outcome

The Journal of Infectious Diseases
2023-02-01 | Journal article
DOI: 10.1093/infdis/jiac431
Part of ISSN: 0022-1899
Part of ISSN: 1537-6613
Contributors: Raquel Binder; Gavin F Fujimori; Catherine S Forconi; George W Reed; Leandro S Silva; Priya Saikumar Lakshmi; Amanda Higgins; Lindsey Cincotta; Protiva Dutta; Marie-Claire Salive et al.
Source: Self-asserted source
Catherine Forconi

The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization

mSphere
2022-08-31 | Journal article
DOI: 10.1128/msphere.00193-22
Part of ISSN: 2379-5042
Contributors: Amy Karger; James D. Brien; Jayne M. Christen; Santosh Dhakal; Troy J. Kemp; Sabra Klein; Ligia Pinto; Lakshmanane Premkumar; John D. Roback; Raquel A. Binder et al.
Source: Self-asserted source
Catherine Forconi

Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles

Cell Reports
2022-06 | Journal article
DOI: 10.1016/j.celrep.2022.110952
Part of ISSN: 2211-1247
Contributors: Aniuska Becerra-Artiles; J. Mauricio Calvo-Calle; Mary Dawn Co; Padma P. Nanaware; John Cruz; Grant C. Weaver; Liying Lu; Catherine Forconi; Robert W. Finberg; Ann M. Moormann et al.
Source: Self-asserted source
Catherine Forconi

Low Complexity of Infection Is Associated With Molecular Persistence of Plasmodium falciparum in Kenya and Tanzania

Frontiers in Epidemiology
2022-06-06 | Journal article
DOI: 10.3389/fepid.2022.852237
Part of ISSN: 2674-1199
Contributors: Hillary M. Topazian; Kara A. Moser; Billy Ngasala; Peter O. Oluoch; Catherine S. Forconi; Lwidiko E. Mhamilawa; Ozkan Aydemir; Oksana Kharabora; Molly Deutsch-Feldman; Andrew F. Read et al.
Source: Self-asserted source
Catherine Forconi

Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies

Open Forum Infectious Diseases
2022-06-01 | Journal article
DOI: 10.1093/ofid/ofac171
Part of ISSN: 2328-8957
Contributors: Jane C Figueiredo; Fred R Hirsch; Lawrence H Kushi; Wendy N Nembhard; James M Crawford; Nicholas Mantis; Laurel Finster; Noah M Merin; Akil Merchant; Karen L Reckamp et al.
Source: Self-asserted source
Catherine Forconi

Interplay between IL-10, IFN-γ, IL-17A and PD-1 Expressing EBNA1-Specific CD4<sup>+</sup> and CD8<sup>+</sup> T Cell Responses in the Etiologic Pathway to Endemic Burkitt Lymphoma

Cancers
2021-10 | Journal article | Author
DOI: 10.3390/cancers13215375
Contributors: Catherine Forconi; David H. Mulama; Priya Saikumar Lakshmi; Joslyn Foley; Juliana A. Otieno; Jonathan D. Kurtis; Leslie J. Berg; John Ong'echa; Christian Münz; Ann Moormann
Source: check_circle
Multidisciplinary Digital Publishing Institute

Association of killer cell immunoglobulin-like receptors with endemic Burkitt lymphoma in Kenyan children.

Scientific reports
2021-05-31 | Journal article
DOI: 10.1038/s41598-021-90596-7
PMID: 34059753
PMC: PMC8166913
Source: Self-asserted source
Catherine Forconi

KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection.

Cell reports
2021-05-01 | Journal article
DOI: 10.1016/j.celrep.2021.109056
PMID: 33951431
Source: Self-asserted source
Catherine Forconi

A New Hope for CD56<sup>neg</sup>CD16<sup>pos</sup> NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases.

Frontiers in cellular and infection microbiology
2020-04-21 | Journal article
DOI: 10.3389/fcimb.2020.00162
PMID: 32373555
PMC: PMC7186373
Source: Self-asserted source
Catherine Forconi

Kaposi Sarcoma-associated herpesvirus infection and endemic Burkitt's lymphoma.

The Journal of infectious diseases
2020-02-19 | Journal article
DOI: 10.1093/infdis/jiaa060
PMID: 32072172
Source: Self-asserted source
Catherine Forconi

Sensitive detection of EBV microRNAs across cancer spectrum reveals association with decreased survival in adult acute myelocytic leukemia.

Scientific reports
2019-12-30 | Journal article
DOI: 10.1038/s41598-019-56472-1
PMID: 31889055
PMC: PMC6937232
Source: Self-asserted source
Catherine Forconi

Immune effector mechanisms in malaria: An update focusing on human immunity.

Parasite immunology
2019-05-09 | Journal article
DOI: 10.1111/pim.12628
PMID: 30972776
Source: Self-asserted source
Catherine Forconi

Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas.

Blood advances
2018-05 | Journal article
DOI: 10.1182/bloodadvances.2017015404
PMID: 29764843
PMC: PMC5965049
Contributors: Forconi CS; Cosgrove CP; Saikumar-Lakshmi P; Nixon CE; Foley J; Ong'echa JM; Otieno JA; Alter G; Münz C; Moormann AM
Source: Self-asserted source
Catherine Forconi via Europe PubMed Central

CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
2018-01 | Journal article
DOI: 10.1111/ajt.14672
PMID: 29377506
Contributors: Gatault P; Al-Hajj S; Noble J; Chevallier E; Piollet M; Forconi C; Gaudy-Graffin C; Thibault G; Miquelestorena-Standley E; Halimi JM et al.
Source: Self-asserted source
Catherine Forconi via Europe PubMed Central

High pathogen burden in childhood promotes the development of unconventional innate-like CD8+ T cells.

JCI insight
2017-08 | Journal article
DOI: 10.1172/jci.insight.93814
PMID: 28768916
PMC: PMC5543908
Contributors: Falanga YT; Frascoli M; Kaymaz Y; Forconi C; Ong'echa JM; Bailey JA; Berg LJ; Moormann AM
Source: Self-asserted source
Catherine Forconi via Europe PubMed Central

Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2016-08 | Journal article
DOI: 10.1016/j.healun.2016.08.014
PMID: 27751774
Contributors: Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C et al.
Source: Self-asserted source
Catherine Forconi via Europe PubMed Central

CMV infection in the donor and increased kidney graft loss: impact of full HLA-I mismatch and posttransplantation CD8(+) cell reduction.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
2013-06 | Journal article
DOI: 10.1111/ajt.12298
PMID: 23731368
Contributors: Gatault P; Halimi JM; Forconi C; Thibault G; Barbet C; Mérieau E; Gaudy-Graffin C; Marlière JF; Goudeau A; Bruyère F et al.
Source: Self-asserted source
Catherine Forconi via Europe PubMed Central

Revisiting the effects of CMV on long-term transplant outcome.

Current opinion in organ transplantation
2010-08 | Journal article
DOI: 10.1097/mot.0b013e32833bd3b5
PMID: 20631617
Contributors: Baron C; Forconi C; Lebranchu Y
Source: Self-asserted source
Catherine Forconi via Europe PubMed Central
How many people are using ORCID?